SCHEMBL3484675

SCHEMBL3484675

CC(C)(C)OC(=O)C(C)(C)Oc1ccc(Oc2ccccc2CBr)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.41
SLC6A4 P31645 9/20 0.41
SLC6A2 P23975 8/20 0.41
SLC6A3 Q01959 7/20 0.41
PPARG P37231 5/20 0.40
HTR2A P28223 5/20 0.38
PPARA Q07869 4/20 0.38
ABCB11 O95342 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
PMP22 Q01453 2/20 0.38
SLC1A5 Q15758 1/20 0.37
FFAR1 O14842 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484445 0.89 SLC1A5 (0.40) RIPK1SLC6A4SLC6A2SLC6A3PPARG
SCHEMBL4041637 0.85 PPARG (0.54) RIPK1SLC6A4SLC6A2SLC6A3PPARG
SCHEMBL3484260 0.80 PPARG (0.47) SLC6A2SLC6A3PPARGHTR2APPARA
SCHEMBL3484606 0.79 MMP2 (0.44) SLC6A4SLC6A2SLC6A3PPARGHTR2A
SCHEMBL18804484 0.75 PPARA (0.46) PPARGHTR2APPARAABCB11CYP1A2
SCHEMBL5083030 0.75 NCOA1 (0.41) RIPK1PPARGCYP3A4TSHRMEN1
SCHEMBL4040101 0.74 PPARA (0.48) RIPK1PPARGPPARASLC1A5CYP2C9
SCHEMBL3484402 0.73 PPARG (0.44) PPARGPPARACYP2C9SMN1; SMN2
SCHEMBL3484168 0.73 PPARA (0.46) SLC6A2SLC6A3PPARGHTR2APPARA
SCHEMBL5727051 0.73 PPARA (0.45) SLC6A2SLC6A3PPARGHTR2APPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 RIPK1 2544/4885SLC6A4 1016/4885SLC6A2 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.